Microalbuminuria has been shown to be a risk factor for cardiovascular and renal disease in patients with hypertension and diabetes as well as in the general population. Urinary albumin excretion over 24 h is considered a ‘gold standard’ to detect microalbuminuria. Few studies have used 24-h urinary albumin excretion to analyze the prevalence of and related factors for microalbuminuira in a general Chinese population. This study included 1980 adults aged 18–69 years from the Shandong-Ministry of Health Action on Salt and Hypertension (SMASH) Project 2011 survey. Blood pressure, height, weight and waist circumference were measured, and a venous blood and timed 24-h urine samples were collected from each participant. Linear and logistic regression analyses were used to test associations between established cardiovascular risk factors and microalbuminuria. The median (25th–75th percentile) of 24-h urinary albumin excretion was 6.1 mg/d (4.5–8.7 mg/d) for all adults, 6.0 mg/d (4.4–8.5 mg/d) for men and 6.2 mg/d (4.6–8.9 mg/d) for women. The overall prevalence of microalbuminuria was 4.1% (95% confidence interval [CI]: 3.2–5.0%), 3.7% (95% CI: 2.9–4.5%) for men and 4.6% (95% CI: 3.7–5.5%) for women. Microalbuminuria was present in 8.1% (95% CI: 6.9–9.3%) of individuals with hypertension, 11.4% (95% CI: 10.0–12.8%) of those with diabetes and 15.6% (95% CI: 14.0–17.2%) of those with both. Multiple logistic regression analysis indicated that systolic blood pressure (odds ratio [OR] 1.02; 95% CI: 1.01–1.03) and fasting blood glucose (OR 1.19; 95% CI: 1.05–1.35) were the independent risk factors for microalbuminuria. Adults in the general population of Shandong Province have a moderate prevalence of microalbuminuria. Those with hypertension and diabetes are at high risk of having microalbuminuria, suggesting the need for screening and early intervention for microalbuminuria among these individuals.
29 December 2023 in International Archives of Occupational and Environmental Health
Background: To evaluate the effects of Urinary Sodium-to-Potassium Ratio Monitored Intensive Salt Reduction Intervention for Community Hypertensive Patients. Methods: This cluster randomized controlled trial was carried out between August 2023 and August 2024 in Yishui County, Shandong Province. All participants were asked to complete the blood and urine sample collection, anthropometric measurement, questionnaires at the baseline and one-year post-intervention survey, with dietary surveys conducted in a subset of participants. A total of 485 hypertensive patients aged 35 to 69 years from 15 villages were recruited at the baseline and randomly allocated in a 1:1:1 ratio to the control group, low-intensity intervention group, or high-intensity intervention group. The control group received management according to the Basic Public Health Service. The low-intensity intervention group received blood pressure monitoring, salt-restriction spoons, and health education. The high-intensity intervention group additionally received self-monitoring of salt intake and health lectures. Final survey was conducted after one year. Results: A total of 471 participants completed follow-up assessments. Compared with the control group, adjusted mixed linear model analysis showed that the systolic blood pressure decreased by 8.45 mmHg (95% confidence interval −13.57 to −3.33) in the low-intensity intervention group and 12.32 mmHg (−17.40 to −7.23) in the high-intensity intervention group. The effects of the high-intensity intervention were more pronounced, with salt intake decreasing by 2.98 g/d (−4.56 to −1.41) and spot urinary sodium-to-potassium ratio decreasing by 1.16 (−1.93 to −0.38). The knowledge and behaviors in intervention groups improved significantly. The intervention effect interacted with baseline hypertension grade (p for interaction = 0.017), with high-intensity intervention demonstrating greater blood pressure reductions in patients with grade 2 or 3 hypertension. Conclusions: The urinary sodium-to-potassium ratio monitored intensive salt reduction intervention was effective in lowering salt intake and blood pressure. Future efforts could integrate intensity salt reduction interventions and urinary sodium-to-potassium ratio monitoring into the Basic Public Health Service to improve health outcomes in hypertensive patients.